News

Between 1990 and 2017 the global deaths attributed to high body mass index more than doubled from 2.2 million to 4.7 million ...
Historically, bone has been recognized primarily for its structural role in the body, but emerging research suggests that it ...
It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
Oregon Health & Science University, in collaboration with Oregon State University, has discovered the structural organization ...
Our lives are filled with binary decisions – choices between one of two alternatives. But what's really happening inside our ...
Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...
The University will not surrender its independence or relinquish its constitutional rights. Neither Harvard nor any other ...
A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.
Structure Therapeutics Inc.’s GPCR share price has surged by 29.14%, which has investors questioning if this is right time to sell.
Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to discontinue development of danuglipron, an oral ...